The Community Guide

- gsearch

Search Results

Narrow Results:

2021 2

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease

CITE Title : Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease Personal Author(s) : Cook, Ryan R.;Torralva, Randy;King, Caroline;Lum, Paula J.;Tookes, Hansel;Foot, C. anyon;Vergara-Rodriguez, Pamela;Rodriguez, Allan;Fanucchi, Laura;Lucas, Gregory. M.;Waddell, Elizabeth N.;Korthuis, P. Todd; Published Date : 11 01 2021;11-01-; Source : Drug Alcohol Depend. 228:109077 URL : https://stacks.cdc.gov/view/cdc/111861 Cook, Ryan R. et al. (2021). Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease. 228 Cook, Ryan R. et al. "Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease" 228 (2021) Cook, Ryan R. et al. "Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease" vol. 228, 2021 Export RIS Citation Information.

:

Cook, Ryan R. ;

Torralva, Randy

11 01 2021 | Drug Alcohol Depend. 228:109077

:

Background.Associations between fentanyl use and initiation and retention on medications for opioid use disorder (MOUD) are poorly understood.Methods....
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)

CITE Title : Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS) Personal Author(s) : Waddell, Elizabeth Needham;Springer, Sandra A.;Marsch, Lisa A.;Farabee, David;Schwartz, Robert P.;Nyaku, Amesika;Reeves, Rusty;Goldfeld, Keith;McDonald, Ryan D.;Malone, Mia;Cheng, Anna;Saunders, Elizabeth C.;Monica, Laura;Gryczynski, Jan;Bell, Kathleen;Harding, Kasey;Violette, Sandra;Groblewski, Thomas;Martin, Wendy;Talon, Kasey;Beckwith, Nicole;Suchocki, Andrew;Torralva, Randy;Wisdom, Jennifer P.;Lee, Joshua D.; Published Date : 9 2021;9-2021; Source : J Subst Abuse Treat. 128:108389 URL : https://stacks.cdc.gov/view/cdc/111317 Waddell, Elizabeth Needham et al. (2021). Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS). 128 Waddell, Elizabeth Needham et al. "Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)" 128 (2021) Waddell, Elizabeth Needham et al. "Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)" vol. 128, 2021 Export RIS Citation Information.

:

Waddell, Elizabeth Needham ;

Springer, Sandra A.

9 2021 | J Subst Abuse Treat. 128:108389

:

The EXIT-CJS (N = 1005) multisite open-label randomized controlled trial will compare retention and effectiveness of extended-release buprenorphine ...